Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | TDO2 | P48775 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.31 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9510248 | 0.84 | IDO1 (0.35) | IDO1TDO2ALOX5CHRNB2CHRNB4 | |
| SCHEMBL15854033 | 0.79 | — | — | |
| SCHEMBL15853738 | 0.79 | — | — | |
| SCHEMBL13921683 | 0.77 | — | — | |
| SCHEMBL10685954 | 0.77 | LMNA (0.33) | IDO1TDO2ALOX5CHRNB2CHRNB4 | |
| SCHEMBL10685947 | 0.77 | CHRNB2 (0.33) | IDO1TDO2CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL10681486 | 0.74 | ALOX5 (0.33) | IDO1TDO2ALOX5CHRNB2CHRNB4 | |
| SCHEMBL12199262 | 0.73 | IDO1 (0.36) | IDO1TDO2ALOX5CHRNB2CHRNB4 | |
| SCHEMBL30295390 | 0.72 | ALOX5 (0.47) | IDO1TDO2ALOX5CHRNB2CHRNB4 | |
| SCHEMBL24328856 | 0.71 | ALOX5 (0.44) | IDO1TDO2ALOX5CHRNB2CHRNB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1007035-A4 | POLYTHIOPHENE ANTI-TUMOR AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2000-11-22 | — | — | EP | disclosed |
| EP-1019399-A1 | ARYL THIOPHENE DERIVATIVES AS PDE IV INHIBITORS | Merck Frosst Canada & Co. (CA) | 2000-07-19 | — | — | EP | disclosed |
| EP-1007035-A1 | POLYTHIOPHENE ANTI-TUMOR AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2000-06-14 | — | — | EP | disclosed |
| CN-1253500-A | Polythiophene anti-tumor agents | PURDUE RESEARCH FOUNDATION (US) | 2000-05-17 | — | — | CN | disclosed |
| US-6034089-A | ASTHMA THERAPY | MERCK & CO., INC. (US) | 2000-03-07 | — | — | US | disclosed |
| WO-1999018099-A1 | ARYL THIOPHENE DERIVATIVES AS PDE IV INHIBITORS | MERCK FROSST CANADA & CO. (CA) | 1999-04-15 | — | — | WO | disclosed |
| WO-1998023269-A1 | POLYTHIOPHENE ANTI-TUMOR AGENTS | PURDUE RESEARCH FOUNDATION (US) | 1998-06-04 | — | — | WO | disclosed |
| US-5741811-A | ADMINISTERING TO CANCER PATIENTS | PURDUE RESEARCH FOUNDATION (US) | 1998-04-21 | — | — | US | disclosed |
| US-5578636-A | Polythiophene anti-tumor agents | PURDUE RESEARCH FOUNDATION (US) | 1996-11-26 | — | — | US | disclosed |
| US-5260319-A | Analgesics | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1993-11-09 | — | — | US | disclosed |
| EP-0435223-A2 | Thienobenzoxepin- and naphthothiophene-derivatives, a process and intermediates for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1991-07-03 | — | — | EP | disclosed |
| US-5006536-A | Thienobenzoxepins and analgesic compositions thereof | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1991-04-09 | — | — | US | disclosed |
| EP-0386778-A1 | Biphenyl derivatives | TANABE SEIYAKU CO., LTD. (JP) | 1990-09-12 | — | — | EP | disclosed |
| US-4952602-A | TREATMENT OF ARTERIOSCLEROSIS | TANABE SEIYAKU COMPANY, LTD. (JP) | 1990-08-28 | — | — | US | disclosed |
| EP-0316939-A2 | Biphenyl derivatives, preparation method, pharmaceutical compositions comprising them and use | Tanabe Seiyaku Co., Ltd. (JP) | 1989-05-24 | — | — | EP | disclosed |
| US-4297489-A | CEPHALOSPORINS | BRISTOL-MYERS COMPANY (US) | 1981-10-27 | — | — | US | disclosed |
| US-4198506-A | INTERMEDIATES FOR THE CORRESPONDING 3-SUBSTITUTED 3-CEPHEM-4-CARBOXYLIC ACIDS | BRISTOL-MYERS COMPANY (US) | 1980-04-15 | — | — | US | disclosed |
| US-4151352-A | CEPHALOSPORINS, BACTERICIDES | BRISTOL-MYERS COMPANY (US) | 1979-04-24 | — | — | US | disclosed |
| US-4100346-A | Certain 7(o-amino-methyl- or methylaminomethylphenyl- or cyclohexadienyl- or thienylacetamide)-3[1-carboxymethyl-(or ethyl- or propyl-)-tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acids | BRISTOL-MYERS COMPANY (US) | 1978-07-11 | — | — | US | disclosed |
| US-4082912-A | ANTIBACTERIAL | BRISTOL-MYERS COMPANY (US) | 1978-04-04 | — | — | US | disclosed |